However, no significant difference was noted in the plasma MIC-1 levels between the responders and non-responders before treatment, suggesting that baseline MIC-1 levels in CHC patients were not significant predictors of interferon efficacy. This evidence concerns the gene GDF15 and cryohydrocytosis.